Target intelligence / Profile preview

Tumor Cell Lysis via Vaccinia Virus-Mediated Oncolysis (VACV Oncolysis)

Target: VACV Oncolysis
Molecular classification: Virus, Oncolytic Virus

Overview

Tumor cell lysis via vaccinia virus-mediated oncolysis refers to the use of genetically engineered or naturally occurring vaccinia viruses (VACV) as oncolytic agents that selectively infect, replicate within, and destroy cancer cells. This process not only directly kills tumor cells but also stimulates systemic anti-tumor immune responses.

Other names: Oncolytic Vaccinia Virus TherapyVaccinia Virus OncolysisVACV-mediated Tumor Lysis

Mechanism of action

Selective infection and replication within tumor cells, leading to direct oncolysis and release of tumor-associated antigens, stimulating anti-tumor immune responses.

Biological functions

Tumor cell lysisImmune stimulationAnti-tumor immunityViral replication

Disease associations

Cancer

Safety considerations

Off-target effects on normal cellsImmunogenicity of the virusPotential for uncontrolled viral replicationPre-existing immunity to vaccinia virusCytokine release syndrome

Biomarkers

Tumor expression of VACV receptors (though generally receptor-independent)Immune cell infiltration within the tumor microenvironmentViral replication rateDAMPs releaseTAA release

Beyond the preview

Go deeper on Tumor Cell Lysis via Vaccinia Virus-Mediated Oncolysis (VACV Oncolysis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Cell Lysis via Vaccinia Virus-Mediated Oncolysis (VACV Oncolysis).

Explore the full profile